EFSD AND JDRF AND LILLY EUROPEAN PROGRAMME IN TYPE I DIABETES RESEARCH 2017

Resumen de la convocatoria:

Esta convocatoria pretende promover proyectos de investigación europeos y países asociados para aumentar el conocimiento de la diabetes tipo 1 mediante investigación clínica y básica, acelerar la aplicación de los avances científicos en la comprensión de la etiología, patogenia, tratamiento y prevención de la diabetes tipo 1 y sus complicaciones, fomentar la investigación traslacional y aumentar la conciencia pública de la magnitud de esta enfermedad.

Este año se financiarán, preferentemente, proyectos dentro de las siguientes temáticas:

• Research with potential to increase understanding of the natural history, pathogenesis, heterogeneity and/or aetiology of human type 1 diabetes.
• Pancreatic beta cell biology and potential human beta cell regenerative approaches.
• Pathophysiology of type 1 diabetes autoimmunity with a focus on potential therapeutic targets and testing of autoantigen-specific immunoregulation of type 1 diabetes;
• Development and/or testing of therapies that slow or stop the progression of type 1 diabetes before symptomatic disease or that preserve beta cell function in new onset type 1 diabetes;
• Biomaterials and novel concepts for implantable, encapsulated beta cell replacement;
• Automated closed loop artificial pancreas systems and/or its components;
• Novel or repurposed therapies to improve glycaemic and overall metabolic control in type 1 diabetes;
• Novel insulins: glucose-responsive insulin, liver-targeted insulin, ultra-rapid insulin, others;
• Therapies that prevent progression of diabetic kidney or eye disease in type 1 diabetes;
• Beta cell targeting for drug delivery and imaging;
• Discovery of diagnostic, prognostic or predictive biomarkers for all stages of type 1 diabetes to enable "smart" clinical trials.

Quién puede solicitarla:

Requisitos de los Solicitantes: